Another important finding of this study is that changes in these epigenetic enzymes correlated with the downregulated expression of c-Myc, another molecule targeted by curcumin in wtp53, mutp53, and also p53-/- colon cancer cells. The gene discussed is MYC; the disease is malignant colon neoplasm.